Healthcare · Diagnostics Research · NASDAQ
| Market cap | $22.61B |
|---|---|
| Trailing P/E | — |
| FCF yield | -1.1% |
| Revenue growth (YoY) | +32.9% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Guardant Health, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Nov 5, 2020 |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Nov 5, 2020 |
| Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Aug 1, 2020 |
| Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | May 31, 2020 |